Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777

Citation
D. Buckley et al., Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777, J PHARM B, 24(4), 2001, pp. 651-657
Citations number
5
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
ISSN journal
07317085 → ACNP
Volume
24
Issue
4
Year of publication
2001
Pages
651 - 657
Database
ISI
SICI code
0731-7085(200102)24:4<651:IAIOAD>2.0.ZU;2-D
Abstract
An unexpected degradation product, greater than 0.10%,was observed in a DMP 777 capsule formulation stored at 40 degreesC/75% r.h. for 3 months and 25 degreesC/60%: r.h. for 2 years. The degradant of interest was prepared in quantity by refluxing the drug substance in dilute acid. A preparative HPLC method was developed to separate the various degradants and to collect eac h as a separate Fraction. Each Fraction was analyzed by the analytical HPLC gradient test method to assure positive identification of each peak and to correlate each peak to the original capsule sample. Key isolated degradati on products were used for structure elucidation with mass spectrometry. and NMR. The major degradant of interest in the capsule formulation was found to be a carboxylic acid resulting from the acid hydrolysis of an amide bond . (C) 2001 Published by Elsevier Science B.V. All rights reserved.